Lymphoma, Non-Hodgkin

Showing NaN - NaN of 21

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, Non-Hodgkin Trial in Worldwide (Fludarabine, Cyclophosphamide, JCAR017)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Santa Monica, California
  • +36 more
Jan 25, 2023

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (JCAR017, Durvalumab,

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • JCAR017
  • +7 more
  • Duarte, California
  • +17 more
Jan 13, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (Standard of Care, JCAR017)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Standard of Care
  • JCAR017
  • Phoenix, Arizona
  • +78 more
Jan 13, 2023

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +125 more
Nov 21, 2022

Lymphoma, Non-Hodgkin, Lymphoma, Nonhodgkin, Lymphoma, B-Cell Trial in United States (lisocabtagene maraleucel)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +3 more
  • lisocabtagene maraleucel
  • Gilbert, Arizona
  • +40 more
Apr 22, 2022

Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Lymphoma, B-Cell
  • +4 more
  • Burbank, California
  • +90 more
Mar 31, 2022

Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Trial in Australia, United States (NKX019)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +9 more
  • NKX019
  • Denver, Colorado
  • +6 more
Jan 19, 2022

Lymphoma, Non-Hodgkin Trial in United States (Hematopoietic Stem Cell Transplant)

Completed
  • Lymphoma, Non-Hodgkin
  • Hematopoietic Stem Cell Transplant
  • Duarte, California
  • +20 more
Dec 7, 2021

Lymphoma, Non-Hodgkin, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)

Completed
  • Lymphoma, Non-Hodgkin
  • HIV Infections
  • Bleomycin sulfate
  • +9 more
  • Los Angeles, California
  • +21 more
Oct 26, 2021

Lymphoma, Non-Hodgkin, Hodgkin Disease, Multiple Myeloma Trial in United States (TXA127, Placebo)

Terminated
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Duarte, California
  • +9 more
Dec 7, 2020

Lymphoma, Non-Hodgkin Trial in Worldwide (pixantrone, cyclophosphamide, vincristine, rituximab, prednisone, Vinorelbine,

Completed
  • Lymphoma, Non-Hodgkin
  • pixantrone, cyclophosphamide, vincristine, rituximab, prednisone
  • Vinorelbine, Oxalplatin, Ifosfasmide, Etoposide, Mitoxatrone, Gemcitabine or Rituximab
  • Fountain Valley, California
  • +98 more
Jan 27, 2020

Lymphoma, Non-Hodgkin Trial in Chicago, Indianapolis (SB-485232, Rituximab)

Completed
  • Lymphoma, Non-Hodgkin
  • Chicago, Illinois
  • +1 more
Jul 24, 2017

Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)

Completed
  • Lymphoma, Large-Cell, Anaplastic
  • Lymphoma, Non-Hodgkin
  • brentuximab vedotin
  • Birmingham, Alabama
  • +21 more
Feb 2, 2017

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in Canada, United States (brentuximab vedotin,

Completed
  • Lymphoma, B-Cell
  • +3 more
  • Birmingham, Alabama
  • +33 more
Oct 14, 2016

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in Worldwide (SGN-40, , rituximab)

Terminated
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +65 more
Feb 6, 2015

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in United States (SGN-40)

Completed
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +13 more
Dec 17, 2014

Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin Trial in United States (PCI-24781)

Completed
  • Lymphoma
  • +2 more
  • San Francisco, California
  • +7 more
Feb 27, 2014

Lymphoma, Non-Hodgkin Trial in Worldwide (Taxane (Cytotoxic, BAY59-8862))

Completed
  • Lymphoma, Non-Hodgkin
  • Taxane (Cytotoxic, BAY59-8862)
  • Miami Beach, Florida
  • +22 more
Oct 10, 2013

Tumors by Site, Lymphoma, Non-hodgkin, Hodgkin Disease Trial in United States (PCI-24781)

Completed
  • Neoplasms by Site
  • +4 more
  • Greenbrae, California
  • +3 more
Sep 26, 2011

Lymphoma, Non-Hodgkin Trial in United States (Recombinant Human Interleukin-2 and Rituximab)

Completed
  • Lymphoma, Non-Hodgkin
  • Recombinant Human Interleukin-2 and Rituximab
  • Tucson, Arizona
  • +32 more
Feb 2, 2006

Lymphoma, Non-Hodgkin Trial in United States (Recombinant Human Interleukin-2 and Rituximab)

Completed
  • Lymphoma, Non-Hodgkin
  • Recombinant Human Interleukin-2 and Rituximab
  • Little Rock, Arkansas
  • +64 more
Feb 2, 2006